Innoviva Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$129.49 | Buy/Sell | $130.51 | 11.21% | 11 | $327.97B |
| ABT | Abbott Laboratories | Outperform |
9
|
$103.95 | Buy/Sell | $118.92 | 20.25% | 7 | $180.83B |
| PFE | Pfizer | Outperform |
2
|
$28.88 | Buy/Sell | $32.87 | 5.51% | 6 | $163.65B |